Barbara M. Goldsmith, PhD

In July 2023, we changed our name from AACC (short for the American Association for Clinical Chemistry) to the Association for Diagnostics & Laboratory Medicine (ADLM). The following page was written prior to this rebranding and contains mentions of the association’s old name. It may contain other out-of-date information as well.

2010 Past President's Award

Barbara M. Goldsmith, PhD, FACB

Dr. Goldsmith is vice president for marketing and business development at the Clinical and Laboratory Standards Institute in Philadelphia and a clinical professor at Tufts University School of Medicine in Boston. A second-generation member of AACC, she has been active in the Association for more than 25 years, serving in a number of national positions including chairing the Membership Task Force, the Pediatric Division, and the 2007 Annual Meeting Organizing Committee. She has held offices in local sections, including chair of the Philadelphia Section. Despite the difficult economic environment, Dr. Goldsmith led the Association through another successful year. The Association’s international efforts were greatly expanded thanks to a grant from the Wallace H. Coulter Foundation to undertake educational training and development in clinical laboratory medicine in countries with limited resources, and Dr. Goldsmith currently chairs the Emerging Countries Task Force. The journal Clinical Chemistry underwent a redesign and added new features, including podcasts of interviews with authors of important articles. The consumer website Lab Tests Online continued to expand, signing agreements to develop Chinese and Turkish versions. The website launched its version 2.0 at the annual meeting last year. AACC expanded its online certificate offerings to include a Clinical Laboratory Leadership and Management program and a Laboratory Support for Diabetes Testing program. The association took a prominent role in the Clinical Laboratory Coalition, an alliance of associations working to represent the field in the debate over health-care reform legislation on issues of vital importance such as laboratory reimbursement.